Discovery of Compounds that Can Bind to Intrinsically Disordered Proteins

来源 :第一届物理化学研究生前沿论坛 | 被引量 : 0次 | 上传用户:lblb0628wto
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Intrinsically disordered proteins (IDPs) show little ordered structures under physiological conditions.Roughly 10% of proteins in various genomes have been predicted to be fully disordered.IDPs occur more often in disease related genes and may be used as potential drug design targets.However, due to its dynamic nature, traditional structure-based drug design approaches are ineffective or even infeasible for designing molecules targeting 1DPs.
其他文献
  石墨烯带隙为零、开关比低,而打开带隙又会导致其迁移率急剧下降.因此,如何制造既具有大开关比又表现高迁移率的石墨烯器件成为当今最热门课题之一.这里,我们理论研究了石墨
  Linear Metal string complexes Nin(L)4Cl2 (n=3, L=di(2-pyridyl)-amido anion(dpa);n=5,L=tripyridyldiamido dianion(tpda);n=7, L=tetranaphthyridyltriamine ligan
  石墨烯具有独特的电学、热学和力学性能,加之其柔性和透明等特点,在很多领域都有着广阔的应用前景。如何低成本、高效制备石墨烯是石墨烯应用的前提。目前CVD法制备石墨烯
  具有d0电子构型的氧化物是光催化分解水研究中最引人关注的一类材料。材料的带隙,绝对能级位置,和表面电子能带结构是光催化材料最为关键的本征性质,决定了其催化性能。由于
  氧还原反应是燃料电池系统中重要的电极反应,通常采用铂基贵金属催化剂。近年来,以替代铂为目标的碳基无金属氧还原催化剂的研究取得了重要进展,但对于氧还原活性的起源或作
  Most studies of drug discovery today are focused on developing small-molecule inhibitors and only small number of enzyme activators has been identified.Howe
  利用化学气相沉积法(CVD)在液态铜催化剂[1]上通过引入Ar实现了石墨烯形貌的精确调控,进一步改变Ar和H2的比例,得到了一系列规律变化的石墨烯图案[2],可控制备了多达20种六
  氧化石墨烯(Graphene Oxide,GeneO)作为一种新型的纳米载体受到各方研究者的关注[1,4],而两亲性的氧化石墨烯可以更好的应用于药物传输体系。本研究在氧化石墨烯表面接枝
  D-3-phosphoglycerate dehydrogenase (PGDH) from Escherichia coli catalyzes the first critical step in serine biosynthesis, and can be allosterically inhibite
  Diphenyldibenzofulvene (DPDBF) molecule presents two forms: ring open and ring closed.The former fluoresces weakly in solution, but it becomes strongly emis
会议